Variant report
Variant | nsv470822 |
---|---|
Chromosome Location | chr6:65518623-65599298 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:76820204..76820882-chr6:65566726..65567360,2 | MCF-7 | breast: | |
2 | chr6:65519121..65521622-chr6:65533277..65535390,2 | MCF-7 | breast: | |
3 | chr6:65519121..65521622-chr6:65533277..65535390,2 | MCF-7 | breast: | |
4 | chr6:65505444..65508032-chr6:65566927..65569730,2 | MCF-7 | breast: | |
5 | chr6:65595975..65598086-chr6:65600070..65602994,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs78313814 | chr6:65521050-65521051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528243774 | chr6:65521081-65521082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs551178640 | chr6:65521082-65521083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546549422 | chr6:65521180-65521181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs368471536 | chr6:65521194-65521195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371008308 | chr6:65521244-65521245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528918420 | chr6:65521247-65521248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548797914 | chr6:65521292-65521293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1495535 | chr6:65521298-65521299 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs35955002 | chr6:65521314-65521315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs397946184 | chr6:65521328-65521329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537604456 | chr6:65521360-65521361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577024331 | chr6:65521392-65521393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs11753113 | chr6:65521398-65521399 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs571173960 | chr6:65521426-65521427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562335256 | chr6:65521441-65521442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs11757912 | chr6:65521475-65521476 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs143425375 | chr6:65521508-65521509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs541902130 | chr6:65521597-65521598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528714522 | chr6:65521617-65521618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573934297 | chr6:65521629-65521630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536689660 | chr6:65521649-65521650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147992021 | chr6:65521670-65521671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576612436 | chr6:65521680-65521681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141574629 | chr6:65521685-65521686 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182670512 | chr6:65521704-65521705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150913887 | chr6:65521752-65521753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs149555723 | chr6:65525604-65525605 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs144236958 | chr6:65525701-65525702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs139951144 | chr6:65525738-65525739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186157236 | chr6:65525790-65525791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192123366 | chr6:65525794-65525795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547968119 | chr6:65525886-65525887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537512728 | chr6:65525901-65525902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs529581967 | chr6:65525927-65525928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551266378 | chr6:65525932-65525933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12192067 | chr6:65525962-65525963 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs35360505 | chr6:65525988-65525989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs75139813 | chr6:65526000-65526001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537085774 | chr6:65526006-65526007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570484643 | chr6:65526011-65526012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183889302 | chr6:65526019-65526020 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189242381 | chr6:65526045-65526046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs117415143 | chr6:65526053-65526054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs539578314 | chr6:65526078-65526079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs190739701 | chr6:65526137-65526138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs370725739 | chr6:65526138-65526139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs552022131 | chr6:65526139-65526140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570407706 | chr6:65526148-65526149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs541734000 | chr6:65526185-65526186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Epilepsy | 20502679 | CNVD |
Dyslexia | 22102821 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:65521000-65521800 | Enhancers | Fetal Stomach | stomach |
2 | chr6:65521000-65521800 | Enhancers | Rectal Smooth Muscle | rectum |
3 | chr6:65525600-65526000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
4 | chr6:65525600-65526200 | Enhancers | HepG2 | liver |
5 | chr6:65532000-65532800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
6 | chr6:65532800-65533400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
7 | chr6:65533400-65534000 | Active TSS | Pancreatic Islets | Pancreatic Islet |
8 | chr6:65533600-65534000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr6:65534000-65534200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
10 | chr6:65543800-65544600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr6:65570000-65571200 | Enhancers | Adipose Nuclei | Adipose |
12 | chr6:65571200-65572200 | Weak transcription | Adipose Nuclei | Adipose |
13 | chr6:65572200-65572400 | Enhancers | Adipose Nuclei | Adipose |
14 | chr6:65588400-65589200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr6:65589200-65589800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr6:65589800-65590000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr6:65597400-65598200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr6:65598000-65598600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr6:65598200-65598400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
20 | chr6:65598200-65600200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
21 | chr6:65599200-65599800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |